MEDIFAST, INC. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↓-36.9% -$44M
$75M
Cost of Revenue↓-25.4% -$8M
$23M
Gross Profit↓-40.9% -$36M
$52M
SG&A↓-31.5% -$28M
$60M
D&A↑+8.8% +$280K
$3M
Operating Income↓-293.8% -$6M
$-4M
EBITDA↓-11.0% -$429K
$3M
Interest Expense↑+74.7% +$712K
$2M
Interest Income↑+7.0% +$93K
$1M
Other Income/Expense↑+99.6% +$526K
$-2K
Pretax Income↓-268.4% -$4M
$-3M
Tax Provision↑+2376.2% +$11M
$12M
Net Income↓-300.3% -$3M
$-2M
Gross Margin↓-4.7pts
69.4%
Operating Margin↓-6.1pts
-4.6%
Net Margin↓-3.3pts
-2.5%
Effective Tax Rate↓-13.5pts
14.9%
Deferred Tax Assets
$648K
Deferred Tax Liabilities
—
ETR (Continuing Operations)↓-275.9pts
-231.1%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↓-71.1pts
-58.3%
ETR Foreign Differential (pp)
—
Operating Lease Cost↑+0.0% +$0
$1M
Revenue YoY Variation↑+0.8pts
-36.9%
Income YoY Variation↓-202.0pts
-293.8%
Revenue QoQ Variation↓-0.9pts
-16.0%
Income QoQ Variation↓-409.6pts
-282.8%